Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancer

Appraisal committee members

The technology appraisal committees are standing advisory committees of NICE. This topic was considered by members of the existing standing committees who have met to reconsider drugs funded by the Cancer Drugs Fund. The names of the members who attended are in the minutes of the appraisal committee meeting, which are posted on the NICE website.

Committee members are asked to declare any interests in the technology to be appraised. If it is considered there is a conflict of interest, the member is excluded from participating further in that appraisal.

NICE project team

Each technology appraisal is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the appraisal), a technical adviser and a project manager.

Pilar Pinilla-Dominguez, Christian Griffiths and Mary Hughes
Technical Leads

Eleanor Donegan
Technical Adviser

Bijal Joshi, Liv Gualda and Thomas Feist
Project Managers

ISBN: 978-1-4731-2465-3